Principal Financial Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $497K | Sell |
|
|||||
|
2024
Q1 | $1.15M | Buy |
|
|||||
|
2023
Q4 | $1.15M | Buy |
|
|||||
|
2023
Q3 | $583K | Buy |
|
|||||
|
2023
Q2 | $845K | Sell |
|
|||||
|
2023
Q1 | $687K | Sell |
|
|||||
|
2022
Q4 | $943K | Buy |
|
|||||
|
2022
Q3 | $715K | Sell |
|
|||||
|
2022
Q2 | $669K | Buy |
|
|||||
|
2022
Q1 | $849K | Sell |
|
|||||
|
2021
Q4 | $788K | Buy |
|
|||||
|
2021
Q3 | $248K | Buy |
|